ColetteJoanShenMD

Radiation Oncology • Chapel Hill, NC

Physician

Join to view full profile

Dr. Shen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shen's full profile

Already have an account?

Office
101 Cb 7512
Chapel Hill, NC 27599
Phone+1 984-974-8418

Education & Training

Johns Hopkins UniversityResidency, Radiation Oncology, 2013 - 2017
Perelman School of Medicine at the University of PennsylvaniaClass of 2012

Certifications & Licensure

NC State Medical License 2017 - 2025
DC State Medical License 2012 - 2013
VA State Medical License 2012 - 2013
American Board of Radiology Radiation Oncology

Clinical Trials

MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets Start of enrollment: 2019 Dec 04
Recruiting
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM Start of enrollment: 2020 Dec 08
Active, not recruiting
Not Applicable
Roles: Contact
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases Start of enrollment: 2022 Mar 09
Recruiting
Phase 1, Phase 2
Roles: Sponsor-Investigator, Contact, Principal Investigator

Publications & Presentations

PubMed

Extended nnU-Net for Brain Metastasis Detection and Segmentation in Contrast-Enhanced Magnetic Resonance Imaging With a Large Multi-Institutional Data Set.
Youngjin Yoo, Eli Gibson, Gengyan Zhao, Thomas J Re, Hemant Parmar
International Journal of Radiation Oncology, Biology, Physics. 2025-01-01
Identifying dose constraints for the parotid ducts to minimize patient-reported xerostomia: Is conventional mean dose sparing of the parotid glands sufficient?
Manal Ahmidouch, Shiva K Das, Tong Zhu, Colette Shen, Lawrence B Marks
Journal of Applied Clinical Medical Physics. 2024-12-01
Association between tumor location and toxicity outcomes after stereotactic radiosurgery for brain metastases.
Boya Wang, Alexandra Bukowski, Orit Kaidar-Person, James M Choi, Deanna M Sasaki-Adams
Journal of Neuro-Oncology. 2024-11-15

Press Mentions

NANOBIOTIX to Present First Survival Data from Priority Head and Neck Cancer Program Among Five Presentations at the 2021 Annual Meeting of the American Society for Radiation OncologyOctober 7th, 2021
NANOBIOTIX Reports New Data for Potential First-in-Class Radioenhancer NBTXR3 in Combination with Anti-PD-1 Showing Local or Distant Tumor Regression in 76.9% of Evaluable Patients Regardless of Prior Anti-PD-1 ExposureJune 3rd, 2021
AACR-AHNS Head and Neck Cancer Conference: Highlights from the Cutting EdgeAugust 4th, 2023